active psoriatic arthritis (PsA) Archives - Elixi International

3 November 2021

Cyltezo(adalimumab-adbm), the First Interchangeable Biosimilar to Humira

26 January 2021

RINVOQ™ (Upadacitinib), approved for the Treatment of Psoriatic Arthritis and Ankylosing Spondylitis

26 November 2020

European Commission Approves Janssen’s TREMFYA (guselkumab), a First-in-Class Treatment for Active Psoriatic Arthritis (PsA)